India-US trade deal clarity: Pharma exporters gain edge in US; sector eyes growth boost
Indian drugmakers anticipate significant benefits from the proposed India-US trade agreement, offering much-needed clarity and stability for the lucrative US pharmaceutical market. This development is expected to boost expansion plans and growth prospects for major companies like Sun Pharma and Dr. Reddy’s, enhancing their competitive edge and strengthening India’s role in global supply chains.🕒 1 min read
Indian drugmakers anticipate significant benefits from the proposed India-US trade agreement, offering much-needed clarity and stability for the lucrative US pharmaceutical market. This development is expected to boost expansion plans and growth prospects for major companies like Sun Pharma and Dr. Reddy’s, enhancing their competitive edge and strengthening India’s role in global supply chains.
Continue Reading
- Peaky Blinder Casino
- AGI 5-10 yrs away, science to surge, jobs to shift: Hassabis
-
Gautam Gambhir’s Unmissable ‘Surrender’ Post After India’s Oval Test Win
-
Ashoka Emblem At J&K’s Hazratbal Shrine Damaged, BJP Says “Terrorist Act”
-
“What Are These Guys Smoking?” India A Blasted For Vaibhav Suryavanshi’s Super Over Snub
- Lenskart IPO: Ahead of listing, GMP plunges 70%; what analysts are saying
-
Pathan crowns Shubman Gill-Sai Sudharsan ‘best batting pair in IPL history’
- Japan’s JFE to buy 50% in Bhushan’s steel business
- Man Arrested For Stabbing Wife To Death In Gurugram
- UP Man Shoots Girlfriend After Family Fixes Her Marriage
